🇺🇸 FDA
Patent

US 8703921

Compositions and methods for delivering inhibitory oligonucleotides

granted A61KA61K31/713A61K47/642

Quick answer

US patent 8703921 (Compositions and methods for delivering inhibitory oligonucleotides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/713, A61K47/642, A61K47/6455, A61P